Abstract
The effect of potent sheep anti-mouse interferon globulin was investigated in several different experimental virus diseases of mice. In anti-interferon globulin-treated mice infected intraperitoneally with herpes simplex virus (HSV) type I, the latent period was shortened, and the overall LD50 was increased several hundredfold compared to virus-infected control mice. When HSV was inoculated subcutaneously all anti-interferon globulin-treated mice died, whereas only 5% of virus-infected control mice died. Subsequent treatment with anti-interferon globulin of previously HSV-infected mice did not result in reactivation of HSV. Treatment of adult mice with anti-interferon globulin resulted in an earlier appearance of MSV-induced tumors, a greater number of mice bearing tumors, an increase in tumor size, and an increase in the duration of tumors. All tumors eventually regressed despite reinjection of anti-interferon globulin. Anti-interferon globulin treatment resulted in a rapid onset of disease and death in adult mice inoculated (intranasal) with VSV and in newborn mice infected with NDV. Anti-interferon globulin exerted no effect on the course of influenza virus infection of mice. We conclude that the early production of interferon is an importane element in the response of the mouse to several viruses exhibiting different pathogeneses.
Full Text
The Full Text of this article is available as a PDF (376.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman L. D. Inhibition of oncogenicity of murine sarcoma virus (Harvey) in mice by interferon. Nature. 1970 Sep 26;227(5265):1349–1350. doi: 10.1038/2271349a0. [DOI] [PubMed] [Google Scholar]
- Chany C., Robbe-Maridor F. Enhancing effect of the murine sarcoma virus (MSV) on the replication of the mouse hepatitis virus (MHV) in vitro. Proc Soc Exp Biol Med. 1969 May;131(1):30–35. doi: 10.3181/00379727-131-33798. [DOI] [PubMed] [Google Scholar]
- Ejercito P. M., Kieff E. D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol. 1968 May;2(3):357–364. doi: 10.1099/0022-1317-2-3-357. [DOI] [PubMed] [Google Scholar]
- Gresser I., Tovey M. G., Bourali-Maury C. Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice. J Gen Virol. 1975 Jun;27(3):395–398. doi: 10.1099/0022-1317-27-3-395. [DOI] [PubMed] [Google Scholar]
- JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING. J Exp Med. 1964 Feb 1;119:343–356. doi: 10.1084/jem.119.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE. J Exp Med. 1964 Sep 1;120:359–374. doi: 10.1084/jem.120.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabin A. B., Olitsky P. K. INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : III. EFFECT OF AGE AND PATHWAY OF INFECTION ON THE CHARACTER AND LOCALIZATION OF LESIONS IN THE CENTRAL NERVOUS SYSTEM. J Exp Med. 1938 Jan 31;67(2):201–228. doi: 10.1084/jem.67.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varet B., Lévy J. P., Leclerc J. C., Senik A. Rôle de l'immunité dans le rejet des tumeurs induites par le virus MSV. Effet des sérums antithymocytes. Int J Cancer. 1968 Nov 15;3(6):727–733. doi: 10.1002/ijc.2910030605. [DOI] [PubMed] [Google Scholar]
- Weinstein A. J., Gazdar A. F., Sims H. L., Levy H. B. Lack of correlation between interferon induction and antitumour effect of poly I-poly C. Nat New Biol. 1971 May 12;231(19):53–54. doi: 10.1038/newbio231053a0. [DOI] [PubMed] [Google Scholar]